These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

291 related articles for article (PubMed ID: 31911292)

  • 1. Current progress in antimalarial pharmacotherapy and multi-target drug discovery.
    Tibon NS; Ng CH; Cheong SL
    Eur J Med Chem; 2020 Feb; 188():111983. PubMed ID: 31911292
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Current scenario of ferrocene-containing hybrids for antimalarial activity.
    Xiao J; Sun Z; Kong F; Gao F
    Eur J Med Chem; 2020 Jan; 185():111791. PubMed ID: 31669852
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Considerations on the mechanism of action of artemisinin antimalarials: part 1--the 'carbon radical' and 'heme' hypotheses.
    Haynes RK; Cheu KW; N'Da D; Coghi P; Monti D
    Infect Disord Drug Targets; 2013 Aug; 13(4):217-77. PubMed ID: 24304352
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quinoline-based antimalarial hybrid compounds.
    Vandekerckhove S; D'hooghe M
    Bioorg Med Chem; 2015 Aug; 23(16):5098-119. PubMed ID: 25593097
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quinolines and artemisinin: chemistry, biology and history.
    Bray PG; Ward SA; O'Neill PM
    Curr Top Microbiol Immunol; 2005; 295():3-38. PubMed ID: 16265885
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hybrid molecules with potential in vitro antiplasmodial and in vivo antimalarial activity against drug-resistant Plasmodium falciparum.
    Feng LS; Xu Z; Chang L; Li C; Yan XF; Gao C; Ding C; Zhao F; Shi F; Wu X
    Med Res Rev; 2020 May; 40(3):931-971. PubMed ID: 31692025
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Advancement of chimeric hybrid drugs to cure malaria infection: An overview with special emphasis on endoperoxide pharmacophores.
    Sharma B; Singh P; Singh AK; Awasthi SK
    Eur J Med Chem; 2021 Jul; 219():113408. PubMed ID: 33989911
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New structural classes of antimalarials.
    Rathod GK; Jain M; Sharma KK; Das S; Basak A; Jain R
    Eur J Med Chem; 2022 Nov; 242():114653. PubMed ID: 35985254
    [TBL] [Abstract][Full Text] [Related]  

  • 9. From hybrid compounds to targeted drug delivery in antimalarial therapy.
    Oliveira R; Miranda D; Magalhães J; Capela R; Perry MJ; O'Neill PM; Moreira R; Lopes F
    Bioorg Med Chem; 2015 Aug; 23(16):5120-30. PubMed ID: 25913864
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combating multi-drug resistant malaria parasite by inhibiting falcipain-2 and heme-polymerization: Artemisinin-peptidyl vinyl phosphonate hybrid molecules as new antimalarials.
    Aratikatla EK; Kalamuddin M; Rana KC; Datta G; Asad M; Sundararaman S; Malhotra P; Mohmmed A; Bhattacharya AK
    Eur J Med Chem; 2021 Aug; 220():113454. PubMed ID: 33901900
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Trioxaquines: hybrid molecules for the treatment of malaria.
    Chauhan SS; Sharma M; Chauhan PM
    Drug News Perspect; 2010 Dec; 23(10):632-46. PubMed ID: 21180649
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quinoline-Based Hybrid Compounds with Antimalarial Activity.
    Nqoro X; Tobeka N; Aderibigbe BA
    Molecules; 2017 Dec; 22(12):. PubMed ID: 29257067
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New dimensions in the field of antimalarial research against malaria resurgence.
    Narula AK; Azad CS; Nainwal LM
    Eur J Med Chem; 2019 Nov; 181():111353. PubMed ID: 31525705
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antimalarial drugs and their useful therapeutic lives: rational drug design lessons from pleiotropic action of quinolines and artemisinins.
    Muregi FW
    Curr Drug Discov Technol; 2010 Dec; 7(4):280-316. PubMed ID: 21034413
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Design, Synthesis, Antimalarial Activity and Docking Study of 7-Chloro-4- (2-(substituted benzylidene)hydrazineyl)quinolines.
    Kalita J; Chetia D; Rudrapal M
    Med Chem; 2020; 16(7):928-937. PubMed ID: 31385774
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drug targets for resistant malaria: Historic to future perspectives.
    Kumar S; Bhardwaj TR; Prasad DN; Singh RK
    Biomed Pharmacother; 2018 Aug; 104():8-27. PubMed ID: 29758416
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Artemisinin-derived antimalarial endoperoxides from bench-side to bed-side: Chronological advancements and future challenges.
    Tiwari MK; Chaudhary S
    Med Res Rev; 2020 Jul; 40(4):1220-1275. PubMed ID: 31930540
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Artemisinin-(Iso)quinoline Hybrids by C-H Activation and Click Chemistry: Combating Multidrug-Resistant Malaria.
    Çapcı A; Lorion MM; Wang H; Simon N; Leidenberger M; Borges Silva MC; Moreira DRM; Zhu Y; Meng Y; Chen JY; Lee YM; Friedrich O; Kappes B; Wang J; Ackermann L; Tsogoeva SB
    Angew Chem Int Ed Engl; 2019 Sep; 58(37):13066-13079. PubMed ID: 31290221
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antimalarial drugs: modes of action and mechanisms of parasite resistance.
    Müller IB; Hyde JE
    Future Microbiol; 2010 Dec; 5(12):1857-73. PubMed ID: 21155666
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quinoline hybrids and their antiplasmodial and antimalarial activities.
    Hu YQ; Gao C; Zhang S; Xu L; Xu Z; Feng LS; Wu X; Zhao F
    Eur J Med Chem; 2017 Oct; 139():22-47. PubMed ID: 28800458
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.